Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
PepGen Inc. (NASDAQ:PEPG) Chief Executive James G. McArthur sold 5,275 shares of common stock on March 4, 2026, to satisfy tax withholding obligations tied to vested restricted stock units, generating total proceeds of $32875. The sale occurred at prices between $6.23 and $6.325 per share. Since the transactions, PepGen shares have slipped to $5.69…
Panos Kozanian, Executive Vice President of Product Engineering at Five9, sold 10,862 shares of common stock on March 4, 2026, for a total of $194,526 under a Rule 10b5-1 plan. The sales were completed in two transactions at prices ranging from $17.49 to $18.07. The filing notes some shares were sold to cover taxes on vested restricted stock units.…
Motorola Solutions Chairman and CEO Gregory Q. Brown sold 28,435 shares of company stock on March 4, 2026, netting roughly $13.5 million across multiple transactions while exercising performance options to acquire 28,435 shares at $81.37 per share. The moves coincide with MSI trading close to a 52-week peak and a valuation flagged as rich by Invest…
Vitale Lucas, Chief Product and Business Operations Officer at Orthofix Medical Inc. (NASDAQ: OFIX), disposed of 2,312 shares across two transactions on March 4 and March 5, 2026, to satisfy tax obligations tied to restricted stock unit settlements. The trades occurred at weighted average prices of $12.9163 and $12.5508, respectively. Following the…
Veracyte Inc. Chief Financial Officer Rebecca Chambers sold 18,341 shares on March 4, 2026, for proceeds totaling $662,869. The sales were made under a Rule 10b5-1 plan adopted in August 2025. The transactions occurred as Veracyte reported stronger-than-expected fourth-quarter 2025 results and management reaffirmed 2026 guidance; analysts issued di…
Phillips 66 Executive Vice President and CFO Kevin J. Mitchell sold 21,800 shares of the company's common stock on March 4 and 5, 2026, generating roughly $3.6 million in proceeds. The transactions, disclosed in a Form 4 filing, came after Mitchell exercised options to acquire the same number of shares at $94.85 per share for a total of $2067729. T…
Take-Two Interactive director Michael Dornemann sold 1,390 shares on March 5, 2026, for $213.09 apiece, a transaction valued at $296,195. The trade occurred as the shares hovered near $211.50, down about 17% year-to-date, and after market services identified the stock as overvalued relative to its Fair Value. Analyst activity following the company’…
Henry Schein Inc. director Laskawy Philip A sold 2,844 shares on March 5, 2026 for $80.36 per share, a transaction worth $228,543. The sale occurred while the stock traded at $77.60 and after the company reported fourth-quarter 2025 results that exceeded earnings and revenue forecasts. Market valuation metrics cited in available research suggest th…
Schrödinger Executive Vice President and Chief Financial Officer Rachit Jain disposed of 1,631 shares of common stock on March 5, 2026, in a transaction executed under a pre-arranged Rule 10b5-1 trading plan. The sale, which generated $21,033 at a weighted average price of $12.896, was reported on a Form 4 filing with the Securities and Exchange Co…
Atlas Energy Solutions Inc. director Douglas G. Rogers reported purchasing 7,000 shares on May 14, 2025, for $92,862, taking his direct stake to 10,000 shares. The company posted mixed fourth-quarter 2025 results with a sizeable EPS miss and a revenue beat, while Stifel raised its price target to $14 and InvestingPro flagged the stock as appearing …
22NW Fund, LP and affiliated entities disposed of 5,124 shares of L.B. Foster Company (NASDAQ: FSTR) common stock on March 4, 2026, generating $163,906 in proceeds. The sale took place close to the stock's 52-week peak, while the company reported fourth-quarter 2025 results that beat revenue expectations but missed earnings per share forecasts by a…
James P. DeMare, Co-President of Bank of America Corp. (NYSE: BAC), disposed of 83,832 shares on March 4, 2026, at $50.00 per share, representing $4.19 million. After the sale, DeMare retains 307,240 shares in a revocable trust. The transaction was disclosed on a Form 4 filing with the SEC. Separately, the bank is managing a series of funding and c…
EverCommerce Inc. President Matthew David Feierstein sold 15,000 shares of company common stock on March 4 and 5, 2026, totaling $181,169. The transactions were executed under a Rule 10b5-1 trading plan put in place August 20, 2025. Following the sales and a tax-withholding disposition, Feierstein retains substantial direct and indirect holdings in…
Nuveen Quality Municipal Income Fund (NYSE:NAD) Vice President William A. Siffermann purchased 100 shares on March 5, 2026, paying $12.0562 per share for a total outlay of $1,205. The purchase was disclosed in a Form 4 filed with the SEC on March 6, 2026. After the trade, Siffermann directly owns 1,041.3222 shares. The fund is trading close to its …
Bank of America Chief Operations Executive Thomas M. Scrivener sold 50,000 shares on March 5, 2026, generating $2.49 million in proceeds. The transaction occurred at prices between $49.82 and $49.83, modestly above the prevailing share price. The sale coincides with a series of corporate financing and strategic moves by the bank, including a planne…
Dave Inc. director Andrea Mitchell sold 29,160 shares of Class A common stock on March 5 and 6, 2026, under a Rule 10b5-1 trading plan, generating proceeds of $6.3 million. The sales come as the fintech prepares a $150 million convertible notes placement, reports stronger-than-expected Q4 2025 results and receives multiple analyst coverage actions.
Alphabet Inc. CEO Sundar Pichai completed $9.8 million in Class C stock sales on March 4, 2026, while acquiring zero-valued Google Stock Units and maintaining substantial direct and indirect holdings. The trades were carried out under a Rule 10b5-1 plan adopted in December 2024. The filings coincide with corporate updates on executive pay and sever…
Robert F. Hoffman, Century Aluminum Co's senior vice president of IT and chief accounting officer, sold 10,000 shares on March 4, 2026, for $563,300. The sale occurred near the stock's 52-week high while the company reported fourth-quarter 2025 EBITDA in line with expectations and pursued a large joint venture to expand U.S. primary aluminum capaci…
Perimeter Solutions director William N. Thorndike Jr. sold 325,000 shares of common stock across three trades from March 4-6, 2026, generating $7,801,500 in proceeds. The transactions, disclosed on a Form 4 filing, leave Thorndike with 8,860,656 shares directly held. The sales occurred as the stock sits near the director's average sale prices after…
A TransMedics Group, Inc. director liquidated a small block of shares worth $178,496 on March 4, 2026, even as the company delivered robust fourth-quarter results and issued 2026 revenue guidance that modestly exceeded analyst expectations. The transaction reduced the director's direct holdings to 2,866 shares. Separately, TransMedics reported a ma…
Krishnan Krish S, President and CEO of Krystal Biotech, executed multiple share sales totaling 23,870 shares on March 4, 2026, producing roughly $6.58 million in proceeds. The trades were carried out under an existing Rule 10b5-1 trading arrangement. The stock is trading below an InvestingPro Fair Value estimate even after notable six-month gains a…
Ligand Pharmaceuticals' Chief Financial Officer, Octavio Espinoza, sold 11,223 shares on March 4, 2026, netting roughly $2.76 million under a pre-established Rule 10b5-1 plan while also exercising options. The trades coincide with the stock trading close to its 52-week high after a strong one-year performance, and follow robust fourth-quarter and f…
Andrew Reardon, Chief Legal Officer and Secretary of Ligand Pharmaceuticals (LGND), sold 4,858 shares on March 4, 2026, for roughly $1.03 million and exercised options to buy 5,000 shares at $52.27. The trades were carried out under a pre-arranged trading plan. Separately, Ligand posted fourth-quarter and full-year 2025 results that beat analysts' …
Rodney Clemente, Senior Vice President for Water at Energy Recovery, Inc. (NASDAQ: ERII), sold 20,568 shares on March 4, 2026, for $218,308 under a pre-arranged Rule 10b5-1 trading plan, according to a Form 4 filing. The transaction occurred as ERII shares traded near a 52-week low and followed a fourth-quarter 2025 earnings and revenue miss and a …
John P. Lauer, Executive Vice President and Chief Commercial Officer of Matson, Inc. (NYSE: MATX), sold 8,603 shares on March 5, 2026, generating $1,429,216 at $166.13 per share. The transaction occurred while the stock traded at $152.99 and after a 46% return over the prior six months. Matson also reported fourth-quarter adjusted EPS of $4.60, bea…
